FDA Inspection 1039082 — SpecGx, LLC
The FDA completed an inspection of SpecGx, LLC on January 26, 2018 in Webster Groves, MO. The inspection was classified NAI (No Action Indicated — no objectionable conditions were found). Product area: Drugs.
Inspection Details
- Classification
- No Action Indicated (NAI) (NAI)
- End Date
- January 26, 2018
- Fiscal Year
- 2018
- Product Type
- Drugs
- Project Area
- Drug Quality Assurance
- Location
- Webster Groves, MO (United States)